Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
The ORIGIN Trial Investigators Hamilton, Ontario, Canada
Research output: Contribution to journal › Article › peer-review
154Scopus
citations
Fingerprint
Dive into the research topics of 'Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)'. Together they form a unique fingerprint.